Daniel A Reed
6PUBLICATIONS
99CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 12, 2025
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.Cecilia R Chambers, Supitchaya Watakul, Peter Schofield
|Jul 03, 2024
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response.Brooke A Pereira, Shona Ritchie, Cecilia R Chambers
|Aug 28, 2023
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer.Jessica L Chitty, Michelle Yam, Lara Perryman
|May 01, 2023
Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouse.James R W Conway, Sean C Warren, Young-Kyung Lee
|Sep 29, 2021
Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status.Kendelle J Murphy, Daniel A Reed, Claire Vennin
|Aug 14, 2019
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan.Claire Vennin, Pauline Mélénec, Romain Rouet
Pageof 1
Frequent Collaborators
6 joint publications
David Herrmann
5 joint publications
Paul Timpson
5 joint publications
Jennifer P Morton
5 joint publications
Thomas R Cox
4 joint publications
Max Nobis
4 joint publications
Kendelle J Murphy
4 joint publications
Sean C Warren
4 joint publications
Brooke A Pereira
4 joint publications
Victoria Lee
4 joint publications
Owen J Sansom
